We are live on
!
Find out more
Sands Capital Management Portfolio holdings
AUM
$25.5B
1-Year Est. Return
26.46%
This Fund
S&P 500
This Quarter
Est. Return
+14.31%
1 Year Est. Return
+26.46%
3 Year Est. Return
+130.81%
5 Year Est. Return
+100.92%
10 Year Est. Return
+877.17%
AUM
$34.4B
AUM Growth
+$3.33B
(+11%)
Cap. Flow
-$523M
Cap. Flow
% of AUM
-1.52%
Top 10 Holdings %
Top 10 Hldgs %
47.08%
Holding
79
New
1
Increased
37
Reduced
36
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$309M |
| 2 |
Sea Limited
SE
|
+$307M |
| 3 |
Zoetis
ZTS
|
+$224M |
| 4 |
Match Group
MTCH
|
+$195M |
| 5 |
Microsoft
MSFT
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$375M |
| 2 |
Edwards Lifesciences
EW
|
+$312M |
| 3 |
Incyte
INCY
|
+$308M |
| 4 |
Palo Alto Networks
PANW
|
+$265M |
| 5 |
Netflix
NFLX
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.7% |
| 2 | Consumer Discretionary | 20.36% |
| 3 | Healthcare | 19.63% |
| 4 | Communication Services | 15.89% |
| 5 | Financials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
MakeMyTrip
MMYT
$5.36B
| $71.7M | 0.21% |
3,132,574
+224,335
| +8% | +$5.43M |
|
52
Roper Technologies
ROP
$38.8B
| $62.6M | 0.18% |
176,674
+58,132
| +49% | +$20.1M |
|
53
Equinix
EQIX
$101B
| $58.9M | 0.17% |
100,940
+26,402
| +35% | +$14.8M |
|
54
Boston Scientific
BSX
$69.5B
| $54M | 0.16% |
1,194,156
+394,072
| +49% | +$16.5M |
|
55
Intercontinental Exchange
ICE
$85.6B
| $52M | 0.15% |
562,186
+185,333
| +49% | +$17.2M |
|
56
UnitedHealth
UNH
$376B
| $47M | 0.14% |
159,706
+52,694
| +49% | +$13.8M |
|
57
IQVIA
IQV
$38.7B
| $45.6M | 0.13% |
295,312
+97,149
| +49% | +$14.2M |
|
58
Dollar General
DG
$28B
| $44.9M | 0.13% |
287,859
+30,146
| +12% | +$4.78M |
|
59
Live Nation Entertainment
LYV
$40.6B
| $42.9M | 0.12% |
600,850
+197,893
| +49% | +$13.4M |
|
60
Verisk Analytics
VRSK
$25.4B
| $40.8M | 0.12% |
272,889
+90,035
| +49% | +$13.3M |
|
61
Ross Stores
ROST
$80.5B
| $40.1M | 0.12% |
344,035
+113,164
| +49% | +$12.7M |
|
62
HUTCHMED
HCM
$1.93B
| $37.8M | 0.11% |
1,506,575
+610,205
| +68% | +$13.4M |
|
|
KRTX
63
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $32.3M | 0.09% |
428,895
-150,000
| -26% | -$6.57M |
|
64
Moody's
MCO
$82.8B
| $30.2M | 0.09% |
127,146
+41,897
| +49% | +$9.31M |
|
65
Health Catalyst
HCAT
$154M
| $28.8M | 0.08% |
889,146
| – | – |
|
66
Union Pacific
UNP
$174B
| $28.7M | 0.08% |
158,570
+52,179
| +49% | +$8.93M |
|
|
ONC
67
BeOne Medicines Ltd
ONC
$32.8B
| $27.7M | 0.08% |
166,923
-97,309
| -37% | -$16.2M |
|
68
Guidewire Software
GWRE
$12.6B
| $13.3M | 0.04% |
120,760
-400
| -0.3% | -$44.7K |
|
|
ANSS
69
DELISTED
Ansys
ANSS
| $12.8M | 0.04% |
49,748
-150
| -0.3% | -$35.5K |
|
70
Crown Castle
CCI
$33.3B
| $11.3M | 0.03% |
79,466
-275
| -0.3% | -$37.5K |
|
|
WORK
71
DELISTED
Slack Technologies, Inc.
WORK
| $8.25M | 0.02% |
367,019
-1,286
| -0.3% | -$28.6K |
|
|
PLAN
72
DELISTED
Anaplan, Inc.
PLAN
| $6.13M | 0.02% |
117,050
-41,546
| -26% | -$2.06M |
|
73
iShares Russell 1000 Growth ETF
IWF
$121B
| $5.99M | 0.02% |
+136,140
| New | +$5.68M |
|
|
EB
74
DELISTED
Eventbrite
EB
| $4.84M | 0.01% |
239,860
-875
| -0.4% | -$16.7K |
|
75
Revolve Group
RVLV
$1.8B
| $3.87M | 0.01% |
210,900
-750
| -0.4% | -$14.2K |
|
Similar funds
KK
VAI
UIM
Sands Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Sands Capital Management held 79 positions worth $34.4B, up 11% from $31.1B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Sands Capital Management's Q4 2019 filing shows 1 new, 37 increased, 36 reduced and 4 closed positions. Its largest new stake was iShares Russell 1000 Growth ETF: 136,140 shares worth $5.99M. The largest sale was BioMarin Pharmaceuticals, an estimated $375M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Sands Capital Management's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 136,140 shares worth $5.99M.
- Sands Capital Management added most to Intuit in Q4 2019, an estimated $309M increase.
- Sands Capital Management's biggest Q4 2019 reduction was Edwards Lifesciences, cutting an estimated $312M.
- Sands Capital Management fully exited BioMarin Pharmaceuticals in Q4 2019, selling an estimated $375M.
- Sands Capital Management's ten largest holdings make up 47% of its $34.4B portfolio in Q4 2019.
- Sands Capital Management opened 1 new position and closed 4 in Q4 2019.
- Sands Capital Management's portfolio value rose 11% quarter-over-quarter to $34.4B.
Based on Sands Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.